The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review (Q36573967)

15 August 2017

4 references

17 June 2019

5 December 2020

18 January 2021

30 July 2022

The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review (English)

1 reference

15 August 2017

cardiovascular disease

1 reference

17 June 2019

1 reference

5 December 2020

1 reference

18 January 2021

N Muszbek

1

1 reference

15 August 2017

D Brixner

2

1 reference

15 August 2017

A Benedict

3

1 reference

15 August 2017

A Keskinaslan

4

1 reference

15 August 2017

Z M Khan

5

1 reference

15 August 2017

1 February 2008

5 references

International Journal of Clinical Practice

15 August 2017

17 June 2019

5 December 2020

18 January 2021

30 July 2022

5 references

15 August 2017

17 June 2019

5 December 2020

18 January 2021

30 July 2022

62

1 reference

15 August 2017

2

1 reference

15 August 2017

338-351

1 reference

Creative Commons Attribution 2.5 Generic

15 August 2017

1 reference

An update on the etiology and epidemiology of diabetes mellitus

30 July 2022

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: a retrospective data analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

A meta-analysis of the association between adherence to drug therapy and mortality

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

The effect of switching on compliance and persistence: the case of statin treatment.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Pharmacoeconomic impact of non-compliance with statins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Global burden of hypertension: analysis of worldwide data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Costs and utilization associated with pharmaceutical adherence in a diabetic population.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

The world health report 2002 - reducing risks, promoting healthy life

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Hypertension treatment and control in five European countries, Canada, and the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Patient adherence and medical treatment outcomes: a meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Some economic consequences of noncompliance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Pharmacoeconomics of hypertension management: the place of combination therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

An economic evaluation of the JNC hypertension guidelines using data from a randomized controlled trial. Joint National Committee.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Noncompliance with antihypertensive therapy. Economic consequences

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Rate and determinants of 10-year persistence with antihypertensive drugs.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

A multicenter disease management program for hospitalized patients with heart failure

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Pharmacoutilization of antihypertensive drugs: a model of analysis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

Recommendations for Evaluating Compliance and Persistence With Hypertension Therapy Using Retrospective Data

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2325652

A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension

4 December 2018

1 reference

12 December 2020

Long-term persistence with antihypertensive drugs in new patients

1 reference

12 December 2020

A pharmacy-based health promotion programme in hypertension: cost-benefit analysis

1 reference

12 December 2020

Treatment for Newly Diagnosed Hypertension: Patterns of Prescribing and Antihypertensive Effectiveness in the UK

1 reference

12 December 2020

Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Labour productivity effects of prescribed medicines for chronically ill workers

1 reference

12 December 2020

Variations in compliance among hypertensive patients by drug class: implications for health care costs

1 reference

12 December 2020

The direct costs to the NHS of discontinuing and switching prescriptions for hypertension

1 reference

12 December 2020

Cost-effectiveness of statins

1 reference

12 December 2020

Impact of medication adherence on hospitalization risk and healthcare cost

1 reference

12 December 2020

Reducing patient drug acquisition costs can lower diabetes health claims

1 reference

12 December 2020

Factors associated with healthcare utilization costs for statin therapy--a pilot study in Hong Kong

1 reference

12 December 2020

Cost-effectiveness analysis of treatments to reduce cholesterol levels, blood pressure and smoking for the prevention of coronary heart disease: evaluative study carried out in Spain

1 reference

12 December 2020

Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance?

1 reference

12 December 2020

10.1111/J.1742-1241.2007.01683.X

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

1 reference